MedTrace Logo

Can People Achieve a Target Omega-3 Index by Following a Personalized Omega-3 Dosing Regimen?

NCT07480707 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2026-03-18

No results posted yet for this study

Summary

The goal of this project is to evaluate the efficacy of personalized dosage recommendations of Parasol Omega-3 Fish Oil on achieving an Omega-3 Index of \>8% in individuals with a baseline Omega-3 Index \<8% over a 90-day period.

Conditions

  • Omega-3 Fatty Acids

Interventions

DIETARY_SUPPLEMENT

Fish Oil Supplementation

Enrolled participants will be instructed to start taking 2 capsules per day on the day they take their baseline O3I and once O3I results are available to adjust to a personalized dose of Fish Oil, based on their baseline Omega-3 Index, and instructed to continue their current omega-3 dietary intake. Recommendations will be: * O3I \> 6.8% but ≤ 8% - 1 capsule * O3I \> 5.5% but ≤ 6.8% - 2 capsules * O3I \> 4.4% but ≤ 5.5% - 3 capsules * O3I ≤ 4.4% - 4 capsules

Sponsors & Collaborators

  • Omegaquant Analytics, LLC

    collaborator UNKNOWN

  • Fatty Acid Research Institute

    lead OTHER

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-05-01
Primary Completion
2026-12-01
Completion
2026-12-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07480707 on ClinicalTrials.gov